Novartis China Drive Paying Off, Sales Soar On Reimbursement Inclusion
Executive Summary
Sales of the Swiss drug maker's major plaque psoriasis treatment Cosentyx in China quadrupled in the second quarter, despite its price being slashed by more than 60%.